Pulmonary function tests (PFTs) are integral to the diagnosis and management of respiratory diseases. However, their interpretation can be complex, requiring a comprehensive understanding of respiratory physiology and pathology. This guide aims to simplify the interpretation process for healthcare professionals.
Spirometry is the cornerstone of PFTs, providing information about airflow and lung volumes. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and their ratio (FEV1/FVC). Abnormal results can indicate obstructive or restrictive lung diseases, with the pattern of changes providing diagnostic clues.
Diffusing capacity of the lungs for carbon monoxide (DLCO) assesses the efficiency of gas exchange across the alveolar-capillary membrane. Reduced DLCO may indicate conditions such as interstitial lung disease, pulmonary hypertension, or emphysema.
Total Lung Capacity (TLC), Functional Residual Capacity (FRC), and Residual Volume (RV) are measured using body plethysmography or gas dilution techniques. Elevated volumes suggest air trapping as seen in obstructive diseases, while reduced volumes indicate restrictive pathology.
Cardiopulmonary exercise testing (CPET) evaluates the integrative exercise responses involving the pulmonary, cardiovascular, hematopoietic, neuropsychological, and skeletal muscle systems. Abnormalities in oxygen uptake, ventilation, or heart rate responses can provide insights into the severity and nature of the disease.
Interpreting PFTs is a multifaceted process that requires a thorough understanding of the tests and their implications. Proficiency in PFT interpretation can greatly enhance clinical decision-making and patient management in respiratory medicine. As healthcare professionals, we must continually strive to enhance our skills in this critical area of practice.
1.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Weight loss trial reports success for breast cancer patients at one year mark
4.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
5.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
1.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
2.
Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders
3.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
4.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
5.
Epigenetic Subtyping of Complex Hematologic Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Updates on the First Line Management of ALK+ NSCLC
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation